Tadataka Yamada, Ph.D., Former Head Of GlaxoSmithKline And Takeda R&D, Re-Joins Frazier Healthcare

MENLO PARK, Calif. & SEATTLE--(BUSINESS WIRE)--Frazier Healthcare, a leading provider of growth capital to healthcare companies, announces that Tadataka Yamada, Ph.D. has re-joined the firm. He will serve as a Venture Partner on the Life Sciences team, focusing on creating companies as well as providing strategic guidance to existing portfolio companies. He will also serve as a Senior Advisor to the Growth Buyout team, where he will provide advice on opportunities in pharmaceutical services and spin-outs from large healthcare companies, and sit on boards of portfolio companies such as PCI, a large pharmaceutical services company in the Frazier portfolio.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC